IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.37B
Enterprise Value 31.71B
Trailing P/E N/A
Forward P/E 119.49
PEG Ratio (5 yr expected) 10.92
Price/Sales (ttm)3.74
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.64
Enterprise Value/EBITDA 6-27.39

Trading Information

Stock Price History

Beta (3Y Monthly) 2.11
52-Week Change 3-41.35%
S&P500 52-Week Change 3-0.33%
52 Week High 316.45
52 Week Low 37.60
50-Day Moving Average 310.20
200-Day Moving Average 311.07

Share Statistics

Avg Vol (3 month) 31.57M
Avg Vol (10 day) 33.83M
Shares Outstanding 5155.62M
Float 142.79M
% Held by Insiders 12.60%
% Held by Institutions 1100.33%
Shares Short (Jul 31, 2019) 418.74M
Short Ratio (Jul 31, 2019) 415.01
Short % of Float (Jul 31, 2019) 414.12%
Short % of Shares Outstanding (Jul 31, 2019) 411.98%
Shares Short (prior month Jun 28, 2019) 417.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/1194
Last Split Date 3Apr 2, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -64.48%
Operating Margin (ttm)-18.76%

Management Effectiveness

Return on Assets (ttm)-9.22%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)367.32M
Revenue Per Share (ttm)2.38
Quarterly Revenue Growth (yoy)26.00%
Gross Profit (ttm)147.14M
EBITDA -62.27M
Net Income Avi to Common (ttm)-241.24M
Diluted EPS (ttm)-1.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.91M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)432.11M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.99
Book Value Per Share (mrq)-1.40

Cash Flow Statement

Operating Cash Flow (ttm)-68.93M
Levered Free Cash Flow (ttm)-63.39M